You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pancreatic Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Identify microRNAs in Cachexia in Pancreatic Carcinoma

Recruiting
  • Resectable Pancreatic Adenocarcinoma
  • Pancreatic cancer microRNA and messenger RNA expression.
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jan 9, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)

Recruiting
  • Neuroendocrine Tumor Grade 3
  • +2 more
  • Tianjin, Tianjin, China
    Rui Liu
Nov 17, 2022

Metastatic Pancreatic Cancer Trial in Shanghai (Iodine125-Seeds implantation, Gem/nab-P Chemotherapy)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Iodine125-Seeds implantation
  • Gem/nab-P Chemotherapy
  • Shanghai, Shanghai, China
    Changhai Hospital
May 11, 2023

Metastatic Pancreatic Carcinoma Trial in Providence (CAR2 Anti-CEA CAR-T cells)

Terminated
  • Metastatic Pancreatic Carcinoma
  • CAR2 Anti-CEA CAR-T cells
  • Providence, Rhode Island
    Roger Williams Medical Center
Jan 12, 2023

Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester

Recruiting
  • Advanced Pancreatic Carcinoma
  • +9 more
  • Endoscopic Ultrasound
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 13, 2022

Pancreatic Carcinoma Trial in Shanghai (carbon ion radiotherapy)

Recruiting
  • Pancreatic Carcinoma
  • carbon ion radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Apr 25, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Pancreatic Cancer Trial in Hangzhou (Canagliflozin and Gemcitabine, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Jun 11, 2023

Use Of Indocyanine Green In Pancreas Surgery

Not yet recruiting
  • Pancreatic Carcinoma
  • Non-Interventional Study
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 11, 2023

Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City

Recruiting
  • Metastatic Pancreatic Carcinoma
  • +6 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Oct 31, 2022

Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

Recruiting
  • Advanced Ovarian Carcinoma
  • +7 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
  • +2 more
Mar 7, 2023

Radiotherapy - Comprehensive Radiobiology Assessment TRial

Not yet recruiting
  • Locally Advanced Cervical Carcinoma
  • +9 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 1, 2023

    Advanced Pancreatic Carcinoma, Advanced Gastric Carcinoma Trial in Shenzhen (Claudin18.2 CAR-T cells)

    Recruiting
    • Advanced Pancreatic Carcinoma
    • Advanced Gastric Carcinoma
    • Claudin18.2 CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    Nov 17, 2022

    Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)

    Not yet recruiting
    • Pancreatic Carcinoma
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Oct 6, 2023

    Quality of Life, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Cancer Trial (ARACOMPLEX®, )

    Not yet recruiting
    • Quality of Life
    • +2 more
    • ARACOMPLEX®
    • placebo
    • (no location specified)
    Nov 28, 2022

    Pancreatic Carcinoma Trial in Nanjing (Tislelizumab, Gemcitabine, Nab paclitaxel)

    Recruiting
    • Pancreatic Carcinoma
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Dec 1, 2022

    Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

    Recruiting
    • Advanced Pancreatic Carcinoma
    • +27 more
    • Gainesville, Florida
    • +3 more
    Jan 3, 2023

    Resectable Colorectal Carcinoma, Resectable Digestive System Carcinoma, Resectable Pancreatic Carcinoma Trial in Houston

    Active, not recruiting
    • Resectable Colorectal Carcinoma
    • +2 more
    • Acupuncture Therapy
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • +6 more
    • (no location specified)
    Aug 4, 2023

    Hepatobiliary Cancer, Pancreatic Cancer, Hepatocellular Carcinoma Trial in Orange (ctDNA Blood Collection)

    Not yet recruiting
    • Hepatobiliary Cancer
    • +5 more
    • ctDNA Blood Collection
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Aug 9, 2022

    Adult Liver Carcinoma, Gastric Carcinoma, Malignant Solid Tumor Trial in Columbus (other, behavioral, procedure)

    Recruiting
    • Adult Liver Carcinoma
    • +3 more
    • Best Practice
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 23, 2022

    Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8

    Recruiting
    • Locally Advanced Pancreatic Carcinoma
    • +3 more
    • Biopsy
    • +5 more
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center EDDOP
    Nov 30, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

    Recruiting
    • Advanced Lymphoma
    • +13 more
    • BET Bromodomain Inhibitor ZEN-3694
    • +2 more
    • New Haven, Connecticut
      Yale University Cancer Center LAO
    Jun 29, 2022

    Advanced Pancreatic Carcinoma Trial in Miramar (HCW9218)

    Not yet recruiting
    • Advanced Pancreatic Carcinoma
    • Miramar, Florida
      HCW Biologics
    Aug 2, 2022